Pharmacogenetic Approach to Treating Drug Dependence: Serotonin Transporter Gene (SLC6A4) Promoter Polymorphisms as Treatment Predictors in Jordanian Arabs

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|10|4|293-305

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.10, Iss.4, 2012-01, pp. : 293-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review

By van der Zwaluw Carmen S   Engels Rutger CME   Buitelaar Jan   Verkes Robbert J   Franke Barbara   Scholte Ron HJ  

Pharmacogenomics, Vol. 10, Iss. 5, 2009-05 ,pp. : 853-866

Future Medicine

Access to resources Recommend Favorite

An overview of ABC and SLC Drug Transporter Gene Regulation

By  

Current Drug Metabolism, Vol. 14, Iss. 2, 2013-02 ,pp. : 253-264

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic Approach for a Better Drug Treatment in Children

By  

Current Pharmaceutical Design, Vol. 16, Iss. 22, 2010-07 ,pp. : 2462-2473

Bentham Science Publishers

Access to resources Recommend Favorite

Serotonin Transporter Promoter Polymorphism in African Americans: Allele Frequencies and Implications for Treatment

By Lotrich F.E.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 2, 2003-01 ,pp. : 145-147

Adis International

Access to resources Recommend Favorite

Eating Disorders, Serotonin Transporter Polymorphisms and Potential Treatment Response

By Gorwood P.  

American Journal of PharmacoGenomics, Vol. 4, Iss. 1, 2004-01 ,pp. : 9-17

Adis International

Access to resources Recommend Favorite